ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,514Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 738

$540K Total Retail Price of All Prescriptions

Rank: 132 out of 738

1,671 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 13,624 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CLONAZEPAM 1,840 1,257 10 1 30
TEMAZEPAM 1,525 1,121 10 2 28
ALPRAZOLAM 1,378 1,057 10 3 17
TRAZODONE HCL 1,283 764 4 1
CITALOPRAM HBR 1,097 857 5 4
PAROXETINE HCL 925 718 6 16
ZOLPIDEM TARTRATE 891 523 7 3
SERTRALINE HCL 874 664 8 5
FLUOXETINE HCL 800 542 9 8
LORAZEPAM 794 569 10 10 34
BUPROPION HCL SR 789 525 10 11 22
ESCITALOPRAM OXALATE 636 519 12 14
MIRTAZAPINE 572 501 13 10
QUETIAPINE FUMARATE 539 439 14 9
RISPERIDONE 538 341 15 2
ESTAZOLAM 432 358 10 16 77
CLORAZEPATE DIPOTASSIUM 262 257 10 17 76
BUSPIRONE HCL 256 174 18 20
SEROQUEL 253 193 19 27
VENLAFAXINE HCL 246 156 20 40
OLANZAPINE 242 133 21 18
ABILIFY 221 124 22 7
VENLAFAXINE HCL ER 199 149 23 19
CYMBALTA 196 129 24 11
BENZTROPINE MESYLATE 179 52 R 25 6
DIVALPROEX SODIUM 168 64 26 23
BUPROPION XL 167 93 27 15
LEXAPRO 154 132 28 35
FLURAZEPAM HCL 147 95 10 29 106
LAMOTRIGINE 142 62 30 12
AMITRIPTYLINE HCL 110 93 R 31 47
DIAZEPAM 103 37 32 60
PRISTIQ ER 101 91 33 41
HYDROXYZINE HCL 88 59 R 34 59
SEROQUEL XR 84 47 35 13
HALOPERIDOL 79 41 36 29
TRIFLUOPERAZINE HCL 78 33 37 57
TRIAZOLAM 72 48 10 38 137
GABAPENTIN 71 23 39 33
LITHIUM CARBONATE 69 39 40 25
HYDROXYZINE PAMOATE 66 22 R 41 32
DONEPEZIL HCL 58 56 42 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.